Endometrial cancer (cancer of the lining of the womb) statistics

Endometrial cancer is the sixth most common cancer in women worldwide (fourteenth most common cancer overall), with 320,000 new cases diagnosed in 2012.

Endometrial cancer often produces symptoms at relatively early stages, so the disease is generally diagnosed early. The overall 5-year survival rate is relatively high, and higher in high-income countries. For example in the US, the 5-year relative survival rate (which compares the 5-year survival of people with the cancer to the survival of others the same age who don't have cancer) for all endometrial cancer cases is about 69%1. Most cases of endometrial cancer are diagnosed at an early stage, which has a 5-year survival rate of over 91%.

The Continuous Update Project Panel judged that there was convincing evidence that body fatness (reflected by BMI, measures of abdominal girth and adult weight gain) increases the risk of endometrial cancer. Glycaemic load is probably a cause of endometrial cancer, and physical activity and coffee both probably protect against this cancer.

Preventability estimates using the new findings from the Continuous Update Project show that about 21% of cases of endometrial cancer in China can be prevented by being physically active and maintaining a healthy weight.

1 American Cancer Society http://www.cancer.org/cancer/endometrialcancer/overviewguide/
Accessed 23/07/13


The countries with the top 20 highest incidence of endometrial cancer in 2012are given in the table below.

  • Barbados had the highest rate of endometrial cancer, followed by the FYR Macedonia and Armenia.
  • About 53 per cent of endometrial cancer cases occurred in more developed countries.
  • The highest incidence of endometrial cancer was in Northern America and Europe; and the lowest incidence in Africa and Asia.
Rank Country Age-Standardised Rate per 100,000 (World)
1 Barbados 34.1
2 FYR Macedonia 29.0
3 Armenia 26.7
4 Luxembourg 24.2
5 Guyana 22.6
6 New Caledonia 22.1
7 United States of America 19.5
8 Slovakia 19.0
9 Czech Republic 18.0
10 Serbia 17.9
11 Bulgaria 17.8
12 Lithuania 17.7
13 Guatemala 17.4
14 Belarus 17.1
15 France, Guadeloupe 17.0
16 Norway 16.9
16 Poland 16.9
18 Latvia 16.7
19 Ukraine 16.6
20 El Salvador 16.3
20 Canada 16.3

Source: Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.1, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2014. Available from: http://globocan.iarc.fr, accessed on 16/01/2015.